Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annals of Oncology

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDI406PMID 16219623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preoperative radiation and irinotecan in combination with 5 fluorouracil (5-FU) and low-dose leucovorin (LV) in locally advanced rectal cancer (LARC)

  2005cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.

  2004cited by this paper
• Preoperative chemoradiation with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma.

  2004cited by this paper
• XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

  2004cited by this paper
• Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.

  2004cited by this paper
• Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers: Preliminary results of the FFCD 9203 randomized trial

  2004cited by this paper
• Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer : Report of the 22921 EORTC phase III trial.

  2004cited by this paper
• Preliminary phase II SOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum.

  2004cited by this paper
• Neoadjuvant therapy with oxaliplatin (OXA) and 5-fluorouracil (5FU) continuous infusion (CI) combined with radiotherapy (RT)in rectal cancer: First results of the Bologna phase II study.

  2004cited by this paper
• Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.

  2003cited by this paper
• Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

  2003cited by this paper
• Preoperative concurrent chemoradiation in locally advanced rectal cancer with 50 Gy and oxaliplatin (OXA), fluorouracil (FU), I-folinic acid (l-LV). The lyon R0-04 phase II trial

  2002cited by this paper
• Efficacy of Preoperative Radiation Therapy for Resectable Rectal Adenocarcinoma When Combined With Oral Tegafur-Uracil Modulated With Leucovorin

  2002cited by this paper
• Quantification of Histologic Regression of Rectal Cancer After Irradiation

  2002cited by this paper
• Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.

  2002cited by this paper
• Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.

  2002cited by this paper
• Long-Term Prognostic Significance of Extent of Rectal Cancer Response to Preoperative Radiation and Chemotherapy

  2002cited by this paper
• The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study

  2002cited by this paper
• Efficacy of Preoperative Radiation Therapy for Resectable Rectal Adenocarcinoma When Combined With Oral Tegafur-Uracil Modulated With Leucovorin: Results From a Phase II Study

  2002cited by this paper
• The Stockholm II trial on preoperative radiotherapy in rectal carcinoma

  2001cited by this paper
• Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

  2001cited by this paper
• Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials.

  2001cited by this paper
• Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer

  2001cited by this paper
• Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

  2001cited by this paper
• Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

  2000cited by this paper
• Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

  2000cited by this paper
• Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial.

  1999cited by this paper
• Pathological features of rectal cancer after preoperative radiochemotherapy

  1998cited by this paper
• Age is not a limiting factor for radical radiotherapy in pelvic malignancies.

  1997cited by this paper
• Pathological features of rectal cancer after preoperative radiochemotherapy

  1997cited by this paper
• Improved survival with preoperative radiotherapy in resectable rectal cancer.

  1997cited by this paper
• Sphincter preservation therapy for distal rectal carcinoma

  1997cited by this paper
• Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.

  1994cited by this paper
• Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.

  1992cited by this paper
• Effective surgical adjuvant therapy for high-risk rectal carcinoma.

  1991cited by this paper
• Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.

  1988cited by this paper
• Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

  1986cited by this paper
• Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

  1986cited by this paper

• Signet ring cell component predicts the response to neoadjuvant chemoradiotherapy in rectal cancer. Long interim results of a single institution experience.

  2022cites this paper
• Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis

  2022cites this paper
• Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal Cancer (PerSeUS-RC01)

  2021cites this paper
• Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer.

  2021cites this paper
• Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer

  2021cites this paper
• Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score‐matched analysis

  2019cites this paper
• Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review.

  2018cites this paper
• Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in locally advanced rectal carcinoma

  2018cites this paper
• Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)

  2018cites this paper
• A feasibility study of Neoadjuvant chemoradiation in locally advanced carcinoma rectum on tumor down staging and sphincter preservation

  2017cites this paper
• Neoadjuvant radiotherapy and chemotherapy in localy advanced rectal cancer: prospective, randomized phase III study, in colaboration with IAEA, ESTRO and UHC “Sestre milosrdnice"

  2017cites this paper
• Recurrent Low Rectal Cancer In A Non-Surgical Patient: Case Report Of The First Multi-Channel Endorectal Brachytherapy Use In Lebanon

  2016cites this paper
• Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson’s disease

  2016cites this paper
• Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis

  2016cites this paper
• How can we determine the best neoadjuvant chemoradiotherapy regimen for rectal cancer

  2015cites this paper
• Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer.

  2015cites this paper
• Pilot Study of Intense Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Retrospective Review of a Phase II Study

  2014cites this paper
• Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation

  2014cites this paper
• More Treatment is not Necessarily Better – Limited Options for Chemotherapeutic Radiosensitization

  2014cites this paper
• A Prospective Study of Preoperative Oxaliplatin and 5-fluorouracil with Concurrent Radiotherapy in Patients with Locally Advanced Rectal Cancer

  2014cites this paper
• Neoadjuvant-intensified treatment for rectal cancer: time to change?

  2013cites this paper
• Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5‐fluorouracil for locally advanced rectal cancer

  2013cites this paper
• Optimizing neoadjuvant therapy for rectal cancer with oxaliplatin.

  2013cites this paper
• Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial.

  2013cites this paper
• Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)

  2013cites this paper
• Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant.

  2012cites this paper
• Chirurgische Ergebnisse nach neoadjuvanter Radiochemotherapie plus Bevacizumab beim Rektumkarzinom

  2012cites this paper
• Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer

  2012cites this paper
• Phase II Trial of Concomitant Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine and Intensity-Modulated Radiotherapy (IMRT) in Rectal Cancer

  2012cites this paper
• The Role of Capecitabine in Locally Advanced Rectal Cancer Treatment

  2012cites this paper
• Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

  2012cites this paper
• Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research?

  2012cites this paper
• Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.

  2012cites this paper
• Clinical Investigation : Gastrointestinal Cancer Four-Week Neoadjuvant Intensity-Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients : A Validation Phase II Trial

  2012cites this paper
• Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience

  2012cites this paper
• Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications.

  2012cites this paper
• Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II–III rectal cancer

  2012cites this paper
• 10 Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer

  2012cites this paper
• Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer

  2012cites this paper
• Potential Novel Drugs to Combine with Radiation in Rectal Cancer

  2012cites this paper
• Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer

  2012cites this paper
• Preoperative Concurrent Chemoradiation for Patients with Locally Advanced Rectal Cancer Experience of a Single Institute

  2012cites this paper
• Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed, Primary Operable, cT3NxM0, Low Rectal Cancer

  2011influential citation
• Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer

  2011cites this paper
• Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study.

  2011cites this paper
• Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution

  2011cites this paper
• Oxaliplatin as a radiosensitizing agent in rectal cancer

  2011cites this paper
• A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.

  2011cites this paper
• Unique considerations in the patient with rectal cancer.

  2011cites this paper
• Progress in the treatment of locally advanced clinically resectable rectal cancer.

  2011cites this paper
• Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: is there still a place for ecoendoscopic ultrasound?

  2011cites this paper
• Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer.

  2011cites this paper
• Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.

  2011cites this paper
• Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.

  2011cites this paper
• Chemoradiation therapy in the management of gastrointestinal malignancies.

  2011cites this paper
• Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer.

  2011cites this paper
• Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.

  2010cites this paper
• Colorectal Cancer: Focus on Capecitabine

  2010cites this paper
• Combined Modality Therapy for Rectal Cancer

  2010cites this paper
• Chemoradiation for rectal cancer: rationale, approaches, and controversies.

  2010cites this paper
• Comparison between Intensified Neoadjuvant Treatment and Standard Preoperative Chemoradiation for Rectal Cancer

  2010cites this paper
• Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.

  2010cites this paper
• Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology

  2010influential citation
• Update on capecitabine alone and in combination regimens in colorectal cancer patients.

  2010influential citation
• Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer d

  2010cites this paper
• Cetuximab and chemoradiation for rectal cancer–is the water getting muddy?

  2010cites this paper
• The impact of preoperative chemoradiotherapy on advanced low rectal cancer

  2010cites this paper
• The role of targeted agents in preoperative chemoradiation for rectal cancer

  2010cites this paper
• Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer

  2010cites this paper
• Phase II Study of Pre-Operative Radiotherapy with Capecitabine and Oxaliplatin for Rectal Cancer and Carcinoembryonic Antigen as a Predictor of Pathological Tumour Response

  2010cites this paper
• Capecitabine for locally advanced and metastatic colorectal cancer: A review.

  2010cites this paper
• Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.

  2009cites this paper
• Rectal cancer.

  2009cites this paper
• Neoadjuvantes Behandlungskonzept

  2009cites this paper
• Chemoradiotherapy in gastrointestinal malignancies.

  2009cites this paper
• Chemoradiation for Rectal Cancer

  2009cites this paper
• Locally Advanced Rectal Cancer: Combined Chemotherapy During Preoperative Radiation Therapy

  2009cites this paper
• Pre-operative Radio-Chemotherapy of Rectal Cancer: Toxicity and Preliminary Results with the Addition of Weekly Oxaliplatin

  2009cites this paper
• Targeting cancers in the gastrointestinal tract: role of capecitabine

  2009cites this paper
• Targeting cancers in the gastrointestinal tract: role of capecitabine

  2009cites this paper
• Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients

  2009cites this paper
• Neoadjuvante und operative Therapie des Rektumkarzinoms

  2009cites this paper
• The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay

  2009cites this paper
• Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.

  2009cites this paper
• Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study.

  2009cites this paper
• Targeting cancers in the gastrointestinal tract: role of capecitabine

  2009cites this paper
• Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study

  2008cites this paper
• Neoadjuvant Chemoradiation for Rectal Cancer

  2008cites this paper
• Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial

  2008cites this paper
• Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement

  2008cites this paper
• Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?

  2008cites this paper
• Capecitabine: an overview of the side effects and their management

  2008cites this paper
• Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.

  2008cites this paper
• Neoadjuvant chemoradiation for rectal cancer: is more better?

  2008cites this paper
• Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review

  2008cites this paper
• Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

  2008cites this paper
• Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.

  2008cites this paper
• Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer.

  2008cites this paper
• Early clinical results from chemoradiation with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer.

  2008cites this paper
• Capecitabine plus oxaliplatin for the treatment of colorectal cancer

  2008cites this paper